| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | May 9, 2025 | HCW Biologics Inc. | CFO | Buy | 95.0 | +8,462 | 24.49% | ✗ | $220K |
| Sep 13, 2023 | Sep 15, 2023 | HCW Biologics Inc. | CFO | Buy | 68.8 | +5,000 | 0.88% | ✗ | $10.5K |
| Sep 11, 2023 | Sep 13, 2023 | HCW Biologics Inc. | CFO | Buy | 78.8 | +10,000 | 1.79% | ✗ | $20.7K |
| Sep 7, 2023 | Sep 8, 2023 | HCW Biologics Inc. | CFO | Buy | 78.8 | +10,000 | 1.82% | ✗ | $19.9K |
| Sep 6, 2023 | Sep 7, 2023 | HCW Biologics Inc. | CFO | Buy | 67.5 | +5,000 | 0.92% | ✗ | $9.7K |
| Jun 9, 2023 | Jun 9, 2023 | HCW Biologics Inc. | CFO | Buy | 83.8 | +20,000 | 3.82% | ✗ | $41.3K |
| Jun 7, 2023 | Jun 8, 2023 | HCW Biologics Inc. | CFO | Buy | 87.5 | +24,696 | 4.95% | ✗ | $51K |
| Jun 5, 2023 | Jun 7, 2023 | HCW Biologics Inc. | CFO | Buy | 90.0 | +39,062 | 8.49% | ✗ | $68.1K |
| May 25, 2023 | May 31, 2023 | HCW Biologics Inc. | CFO | Buy | 90.0 | +40,000 | 9.52% | ✗ | $65.5K |
| May 22, 2023 | May 24, 2023 | HCW Biologics Inc. | CFO | Buy | 95.0 | +58,486 | 16.17% | ✗ | $91.1K |
| Sep 14, 2022 | Sep 15, 2022 | HCW Biologics Inc. | CFO | Buy | 83.8 | +15,000 | 4.79% | ✗ | $38.7K |
| Sep 12, 2022 | Sep 14, 2022 | HCW Biologics Inc. | CFO | Buy | 95.0 | +30,000 | 10.60% | ✗ | $78.4K |
| Aug 30, 2022 | Sep 1, 2022 | HCW Biologics Inc. | CFO | Buy | 86.3 | +17,200 | 6.47% | ✗ | $43.9K |
| Aug 26, 2022 | Aug 30, 2022 | HCW Biologics Inc. | CFO | Buy | 90.0 | +20,000 | 8.14% | ✗ | $51K |
| Aug 24, 2022 | Aug 26, 2022 | HCW Biologics Inc. | CFO | Buy | 95.0 | +90,300 | 58.09% | ✗ | $229.7K |
| Jun 13, 2022 | Jun 15, 2022 | HCW Biologics Inc. | CFO | Buy | 95.0 | +66,452 | 74.67% | ✗ | $160.8K |
| Aug 19, 2021 | Sep 10, 2021 | HCW Biologics Inc. | CFO | Buy | 91.3 | +10,000 | 19.23% | ✗ | $44K |
| Aug 19, 2021 | Aug 23, 2021 | HCW Biologics Inc. | CFO | Buy | 91.3 | +10,000 | 19.23% | ✗ | $44K |
| Jul 22, 2021 | Jul 23, 2021 | HCW Biologics Inc. | CFO | Buy | 95.0 | +25,000 | 92.59% | ✗ | $200K |